¼¼°èÀÇ »êÈÄ ¿ì¿ïÁõ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Postpartum Depression Treatment Global Market Report 2025
»óǰÄÚµå : 1751078
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,170,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,918,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,666,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

»êÈÄ ¿ì¿ïÁõ Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2029³â±îÁö ¿¬Æò±Õ 7.4%ÀÇ CAGR·Î 17¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº »õ·Î¿î ¼ÓÈ¿¼º Ä¡·á¹ý °³¹ß, µðÁöÅÐ Á¤½Å°Ç°­ ¼Ö·ç¼ÇÀÇ Ã¤Åà Ȯ´ë, Á¤½Å°Ç°­ ¼­ºñ½º¿¡ ´ëÇÑ º¸Çè Àû¿ë È®´ë, °³º°È­µÈ Ä¡·á Á¢±Ù¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, È£¸£¸ó ¿ä¹ý¿¡ ´ëÇÑ °ü½É Áõ°¡ µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ½Å°æ ½ºÅ×·ÎÀÌµå ±â¹Ý Ä¡·áÀÇ µîÀå, »êÈÄ °ü¸®¿¡¼­ ¿ø°ÝÀÇ·áÀÇ »ç¿ë Áõ°¡, Á¤½Å°Ç°­ Áø´Ü¿¡ AIÀÇ ÅëÇÕ, ¿µ¾ç º¸ÃæÁ¦¿Í ½ÄÀÌ ÁßÀçÀÇ ¿ªÇÒ Áõ°¡, °í¿ëÁÖ°¡ ÈÄ¿øÇÏ´Â Á¤½Å°Ç°­ ÇÁ·Î±×·¥ÀÇ È®´ë µîÀÌ ÀÖ½À´Ï´Ù.

ÀӽŠÁß Á¤½Å°Ç°­ ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó »êÈÄ ¿ì¿ïÁõ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀӽŠÁß Á¤½Å°Ç°­ ¹®Á¦¿¡´Â ÀÓ»êºÎ¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ Á¤¼­Àû, ½É¸®Àû, Á¤½ÅÀû »óŰ¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¹®Á¦´Â Á¾Á¾ ½ºÆ®·¹½º¿Í È£¸£¸ó º¯È­·Î ÀÎÇØ Áõ°¡ÇÏ¿© Á¤¼­Àû Ãë¾à¼ºÀ» Áõ°¡½ÃŰ°í ¿©¼ºÀÌ ÀӽŠÁß ½ÅüÀû, »çȸÀû, ½É¸®Àû ¿ä±¸¸¦ °ü¸®ÇϱⰡ ´õ ¾î·Á¿öÁý´Ï´Ù. »êÈÄ ¿ì¿ïÁõ Ä¡·á´Â ½½ÇÄ, ºÒ¾È, ÇÇ·Î µîÀÇ Áõ»óÀ» ¿ÏÈ­Çϰí, Á¤¼­Àû ȸº¹·ÂÀ» ³ôÀ̰í, °Ç°­ÇÑ ¸ð¼º¾Ö¸¦ Çü¼ºÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 10¿ù, ¹Ì±¹À» ±â¹ÝÀ¸·Î ÀÓ»êºÎÀÇ Á¤½Å°Ç°­ °³¼±À» À§ÇØ ³ë·ÂÇÏ´Â ºñ¿µ¸® ´ÜüÀÎ MMHLA(Maternal Mental Health Leadership Alliance)´Â ÀÓ»êºÎÀÇ Á¤½Å°Ç°­ »óŰ¡ °¡Àå ÈçÇÑ ÀӽŠÇÕº´ÁõÀ̸ç, ¹Ì±¹¿¡¼­´Â ¿¬°£ 80 ¸¸ °¡Á¤ÀÌ ¿µÇâÀ» ¹Þ´Â´Ù°í º¸°íÇß½À´Ï´Ù. ³î¶ø°Ôµµ ÀÌ·¯ÇÑ »ç·ÊÀÇ 75%°¡ Ä¡·áµÇÁö ¾Ê¾Æ »ê¸ð, ¾Æ±â, °¡Á·¿¡°Ô Àå±âÀûÀÎ À§ÇèÀ» ÃÊ·¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀνÄÀÇ Áõ°¡´Â »êÈÄ ¿ì¿ïÁõ Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

»êÈÄ ¿ì¿ïÁõ Ä¡·á ½ÃÀåÀÇ ±â¾÷µéÀº ƯÈ÷ ó¹æÀü µðÁöÅÐ »êÈÄ ¿ì¿ïÁõ Ä¡·á µî ¿©·¯ Ä¡·á¹ýÀÇ ÅëÇÕÀ» ÅëÇØ Áø´Ü°ú Ä¡·á¿¡ Å« ÁøÀüÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ó¹æÀü µðÁöÅÐ Ä¡·áÁ¦(DTx)´Â »êÈÄ ¿ì¿ïÁõ(PPD)ÀÇ °ü¸® ¹× Ä¡·á¸¦ À§ÇØ ÀÇ·áÁøÀÌ Ã³¹æÇÏ´Â ÀÓ»óÀûÀ¸·Î °ËÁõµÈ ¸ð¹ÙÀÏ ±â¹Ý Ä¡·áÁ¦ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 4¿ù ¹Ì±¹ µðÁöÅÐ Çコ ±â¾÷ Å¥¸®¿À µðÁöÅÐ Ä¡·áÁ¦(Curio Digital Therapeutics)´Â »êÈÄ ¿ì¿ïÁõ¿¡ ´ëÇÑ ÃÖÃÊÀÇ Ã³¹æÀü µðÁöÅÐ Ä¡·áÁ¦ÀÎ ¸¾¸®ÇÁÆ® Ç÷¯½º(Mom Lift Plus)ÀÇ FDA ½ÂÀÎÀ» ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÀÌ 8ÁÖ°£ÀÇ ÇÁ·Î±×·¥¿¡¼­´Â ÀÇ·áÁøÀÇ ¸ð´ÏÅ͸µ ÇÏ¿¡ ÀÎÁöÇൿġ·á(CBT), ÇൿȰ¼ºÈ­Ä¡·á(BAT), ´ëÀΰü°èÄ¡·á(IPT), º¯Áõ¹ýÀû Çൿġ·á(DBT)°¡ ¸ð¹ÙÀÏ ±â±â¸¦ ÅëÇØ ÀÌ·ç¾îÁý´Ï´Ù. Áß¿äÇÑ ¿¬±¸ °á°ú¿¡ µû¸£¸é, ¾ö¸¶¸®ÇÁÆ® Ç÷¯½º »ç¿ëÀÚÀÇ ¿¡µç¹ö·¯ »êÈÄ ¿ì¿ïÁõ ôµµ(EPDS) Á¡¼ö°¡ ´ëÁ¶±º¿¡ ºñÇØ ÀÓ»óÀûÀ¸·Î À¯ÀǹÌÇÏ°Ô °³¼±µÈ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. À̹ø FDA ½ÂÀÎÀ¸·Î °æÁõ¿¡¼­ ÁߵÀÇ PPD¸¦ Ä¡·áÇÒ ¼ö ÀÖ´Â ºñ¾à¹°Àû ´ë¾ÈÀÌ ¿©¼ºµé¿¡°Ô º¸´Ù Ä£¼÷ÇÏ°Ô ´Ù°¡°¥ ¼ö ÀÖ°Ô µÆ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Postpartum depression (PPD) treatment refers to the medical and psychological care provided to individuals experiencing depression after childbirth. It typically involves a combination of therapy, medication, and support strategies aimed at alleviating symptoms such as persistent sadness, anxiety, fatigue, and difficulty bonding with the baby. Treatment options include medications, psychotherapy, hormonal therapy, and lifestyle interventions designed to improve maternal mental health and overall well-being.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of postpartum depression treatment include postpartum anxiety, postpartum blues, postpartum post-traumatic stress disorder (PTSD), postpartum obsessive-compulsive disorder (OCD), postpartum panic disorder, and postpartum psychosis. Postpartum anxiety is a condition in which new mothers experience excessive worry, fear, or nervousness after childbirth. Treatment options such as antidepressants, hormone therapy, psychotherapy, and other interventions are available for various demographics, including adolescents and adults. These treatments are distributed through various sales channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The postpartum depression treatment market research report is one of a series of new reports from The Business Research Company that provides postpartum depression treatment market statistics, including postpartum depression treatment industry global market size, regional shares, competitors with a postpartum depression treatment market share, detailed postpartum depression treatment market segments, market trends and opportunities, and any further data you may need to thrive in the postpartum depression treatment industry. This postpartum depression treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The postpartum depression treatment market size has grown strongly in recent years. It will grow from $1.19 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to increasing awareness of maternal mental health, the growing prevalence of postpartum depression, advancements in antidepressant medications, rising acceptance of psychotherapy, and government initiatives supporting maternal mental health.

The postpartum depression treatment market size is expected to see strong growth in the next few years. It will grow to $1.70 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth during the forecast period can be attributed to the development of novel fast-acting treatments, the increasing adoption of digital mental health solutions, expanding insurance coverage for mental health services, rising demand for personalized treatment approaches, and a growing focus on hormonal therapies. Key trends expected in the forecast period include the emergence of neurosteroid-based therapies, the increasing use of telemedicine for postpartum care, the integration of AI in mental health diagnostics, the growing role of nutraceuticals and dietary interventions, and the expansion of employer-sponsored mental health programs.

The growing awareness of mental health issues during pregnancy is expected to drive the growth of the postpartum depression treatment market. Mental health issues during pregnancy encompass a range of emotional, psychological, and psychiatric conditions that affect women while they are pregnant. These issues are often heightened due to stress and hormonal changes, which can increase emotional vulnerability and make it more challenging for women to manage the physical, social, and psychological demands of pregnancy. Postpartum depression treatment helps alleviate symptoms such as sadness, anxiety, and fatigue, enhancing emotional resilience and fostering healthier mother-child bonding. For example, in October 2024, the Maternal Mental Health Leadership Alliance (MMHLA), a US-based nonprofit dedicated to improving maternal mental health, reported that maternal mental health conditions are the most common pregnancy complication, affecting 800,000 U.S. families annually. Alarmingly, 75% of these cases go untreated, posing long-term risks to mothers, babies, and families. This growing awareness is a major driver of the postpartum depression treatment market.

Companies in the postpartum depression treatment market are making significant advancements in diagnosis and treatment, particularly through the integration of multiple therapeutic modalities, such as prescription digital postpartum depression treatments. Prescription digital therapeutics (DTx) are clinically validated, mobile-based treatments that healthcare providers prescribe to manage and treat postpartum depression (PPD). For example, in April 2024, Curio Digital Therapeutics Inc., a US-based digital health company, announced FDA clearance for MamaLift Plus, the first prescription digital therapeutic for postpartum depression. This eight-week program delivers cognitive behavioral therapy (CBT), behavioral activation therapy (BAT), interpersonal therapy (IPT), and dialectical behavior therapy (DBT) via mobile devices under healthcare provider supervision. A pivotal study showed significantly higher rates of clinically meaningful improvement in Edinburgh Postnatal Depression Scale (EPDS) scores for MamaLift Plus users compared to a control group. This FDA clearance offers women a non-pharmaceutical option for treating mild to moderate PPD, making it more accessible.

In December 2022, Biogen Inc., a US-based company focusing on neurology therapies, partnered with Sage Therapeutics Inc. to develop treatments for major depressive disorder (MDD) and postpartum depression (PPD). This collaboration allows the companies to work together on medications for PPD, MDD, various mental health conditions, and neurological disorders such as essential tremors. Sage Therapeutics is a US-based company specializing in treatments for neurological conditions, including postpartum depression.

Major players in the postpartum depression treatment market are Biogen Inc., Inspira Health Network, LifeStance Health Inc., Max Healthcare Institute Limited, American Well Corporation, Sakra Premium Hospital Private Limited, Talkspace Inc., Mental Health America, 7 Cups Inc., Marinus Pharmaceuticals Inc., Brii Biosciences Limited, Beyond Blue Ltd, Blooming Wellness Center, Sage Therapeutics Inc., NURX Inc., Curio Digital Therapeutics Inc., Genesis Lifestyle Medicine, Postpartum Society of Florida, TalktoAngel, The Motherhood Center.

North America was the largest region in the postpartum depression treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in postpartum depression treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the postpartum depression treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The postpartum depression treatment market consists of revenues earned by entities by providing services such as psychotherapy, medication management, counseling, digital mental health solutions, and alternative therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The postpartum depression treatment market also includes sales of antidepressant medications, hormone-based therapies, digital health platforms, telehealth services, wearable devices, and mobile applications that support mental health management. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postpartum Depression Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postpartum depression treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for postpartum depression treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postpartum depression treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Postpartum Depression Treatment Market Characteristics

3. Postpartum Depression Treatment Market Trends And Strategies

4. Postpartum Depression Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Postpartum Depression Treatment Growth Analysis And Strategic Analysis Framework

6. Postpartum Depression Treatment Market Segmentation

7. Postpartum Depression Treatment Market Regional And Country Analysis

8. Asia-Pacific Postpartum Depression Treatment Market

9. China Postpartum Depression Treatment Market

10. India Postpartum Depression Treatment Market

11. Japan Postpartum Depression Treatment Market

12. Australia Postpartum Depression Treatment Market

13. Indonesia Postpartum Depression Treatment Market

14. South Korea Postpartum Depression Treatment Market

15. Western Europe Postpartum Depression Treatment Market

16. UK Postpartum Depression Treatment Market

17. Germany Postpartum Depression Treatment Market

18. France Postpartum Depression Treatment Market

19. Italy Postpartum Depression Treatment Market

20. Spain Postpartum Depression Treatment Market

21. Eastern Europe Postpartum Depression Treatment Market

22. Russia Postpartum Depression Treatment Market

23. North America Postpartum Depression Treatment Market

24. USA Postpartum Depression Treatment Market

25. Canada Postpartum Depression Treatment Market

26. South America Postpartum Depression Treatment Market

27. Brazil Postpartum Depression Treatment Market

28. Middle East Postpartum Depression Treatment Market

29. Africa Postpartum Depression Treatment Market

30. Postpartum Depression Treatment Market Competitive Landscape And Company Profiles

31. Postpartum Depression Treatment Market Other Major And Innovative Companies

32. Global Postpartum Depression Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Postpartum Depression Treatment Market

34. Recent Developments In The Postpartum Depression Treatment Market

35. Postpartum Depression Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â